Charlson comorbidity index predicts early failure and overall survival of vascular access among diabetic dialysis patients.

被引:0
|
作者
Alfaro Sanchez, Christian Israel [1 ]
Marin Franco, Antonio Jose
Paz Sorribes, Ma [2 ]
Martinez-Vaquera, Shaira [2 ]
机构
[1] Diaverum Galicia, Pontevedra, Spain
[2] Diaverum Spain, Madrid, Spain
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
2833
引用
收藏
页码:I2475 / I2475
页数:1
相关论文
共 31 条
  • [21] Utility of a modified age-adjusted Charlson Comorbidity Index in predicting cause-specific survival among patients with gastric cancer
    Koseki, Yusuke
    Hikage, Makoto
    Fujiya, Keiichi
    Kamiya, Satoshi
    Tanizawa, Yutaka
    Bando, Etsuro
    Terashima, Masanori
    EJSO, 2021, 47 (08): : 2010 - 2015
  • [22] CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED NSCLC: A RETROSPECTIVE ANALYSIS OF THE IMPACT OF PERFORMANCE STATUS, CHARLSON COMORBIDITY INDEX, BODY MASS INDEX AND HEMOGLOBIN AND C-REACTIVE PROTEIN LEVELS ON OVERALL SURVIVAL
    Takahashi, Tiago K.
    Barbosa, Caroline C. L.
    Hoff, Paulo M.
    Castro, Gilberto, Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S581 - S581
  • [23] High CD49d protein expression predicts short overall survival and early progression in chronic lymphocytic leukemia patients.
    Gattei, Valter
    Bulian, Pietro
    Del-Principe, Maria Ilaria
    Zucchetto, Antonella
    Maurillo, Luca
    Buccisano, Francesco
    Bomben, Riccardo
    Dal-Bo, Michele
    Luciano, Fabrizio
    Rossi, Francesca M.
    Degan, Massimo
    Amadori, Sergio
    Del-Poeta, Giovanni
    BLOOD, 2007, 110 (11) : 911A - 911A
  • [24] HEMODIALYSIS VASCULAR ACCESS PRACTICES AMONG MAINTENANCE HEMODIALYSIS PATIENTS IN A LARGE, NATIONAL, DIALYSIS COHORT IN INDIA AND IMPACT ON SURVIVAL
    Jha, Vivekanand
    Shah, Kamal
    Chhabra, Manik
    Parikh, Kamlesh
    Venkatraman, G.
    Guruvulu, S.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [25] Risk Factors for Early Failure of Arteriovenous Vascular Access Among Patients With Type 2 Diabetes Mellitus
    Yap, Yit-Sheung
    Chuang, Hung-Yi
    Wu, Chien-Hung
    Chi, Wen-Che
    Lin, Cheng-Hao
    Liu, Yi-Chun
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (02) : 112 - 117
  • [26] Associations between Body Mass Index in Hemodialysis Patients and Comorbidity, Dialysis Adequacy, Blood Pressure Control, Vascular Access Type, and Hospital Admission Rate
    AlSahli, Lama. M.
    AlHinti, Sara
    AlOmar, Razan
    AlSulaimani, Aseel
    Abdallah, Mubarak
    Al-Sayyari, Abdulla
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2021, 32 (06) : 1577 - 1585
  • [27] Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients.
    Saad, Fred
    Carles, Joan
    Gillessen, Silke
    Heinrich, Daniel
    Gratt, Jeremy
    Miller, Kurt
    Nilsson, Sten
    O'Sullivan, Joe
    Tucci, Marcello
    Wirth, Manfred
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Final results of a comorbidity and risk factor analysis in consecutive multiple myeloma (MM) patients (pts): development of an easily assessable MM-specific risk score (Freiburger Comorbidity Index [FCI]) and comparison with previously established comorbidity indices (CIs), namely Kaplan Feinstein (KF), Charlson-Comorbidity (CCI), Satariano (SI), Hematopoietic cell transplantation-specific comorbidity index (HCT-CI) on progression free survival (PFS) and overall survival (OS)
    Terhorst, M.
    Kleber, M.
    Ihorst, G.
    Engelhardt, M.
    ONKOLOGIE, 2010, 33 : 92 - +
  • [29] IS THERE A BENEFIT OF LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN OUR PATIENTS WITH MULTIPLE CO-MORBIDITIES?: AGE-ADJUSTED CHARLSON COMORBIDITY INDEX (ACCI) AS A PREDICTOR OF SURVIVAL IN MEDICALLY INOPERABLE EARLY STAGE NON SMALL CELL LUNG CANCER PATIENTS TREATED WITH DEFINITIVE RADIOTHERAPY
    Pantarotto, Jason R.
    Holmes, Oliver
    Nair, Vimoj J.
    Macrae, Robert
    Cross, Peter
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S544 - S545
  • [30] Comparison of 4 Previously Established, but Highly Different Comorbidity Scores (Kaplan Feinstein Index [KF], Charlson-Comorbidity Index [CCI], Satariano Index [SI], Hematopoietic cell transplantation-specific comorbidity index [HCT-CT]) Identifies the KF and HCT-CI as Most Relevant, but Use of An Easily Applied 3-Risk-Factor (KLeber)-Score Suggests to Even More Effectively Predict Progression-Free- and Overall-Survival Differences in Multiple Myeloma (MM) Patients (pts).
    Terhorst, Meike
    Kleber, Martina
    Ihorst, Gabriele
    De Pasquale, David
    Engelhardt, Monika
    BLOOD, 2009, 114 (22) : 714 - 715